SHARE APPRECIATION RIGHT.
docx
A.
2021 (200 employees)
Accrued salaries payable
Salaries
Share appreciation rights not yet exercised 60,000
Multiply: FV 148
Accrued liability- December 31, 2020 8,800,000
Salaries
Cash
Share appreciation rights exercised 40,000
(200 employees x 200 shares)
Multiply: Intrinsic value 145
Total: 5,800,000
2022 (300 employees)
Accrued salaries payable
Salaries
Cash
Share appreciation rights exercised 60,000
(300 employees x 200 shares)
Multiply: Intrinsic value 148
Total: 8,800,000
Accrued liability- December 31, 2021 (8,800,000)
Net compensation expense for 2022 0
B.
2018
Salaries
Accrued salaries payable
MV on Dec. 31, 2018 360
Predetermined price 300
Excess 60
Multiply: No. of shares (200 x 500 employees) 100,000
Total compensation 6,000,000
Compensation for 2018 (6,000,000 x
C.
1. FV of share alternative (25,000 x P48) 1,200,000
FV of liability on grant date (20,000 x P51) 1,020,000
FV of Equity Component 180,000
2. 2018
12-31 Salaries (180,000x 3) 60,000
Share options outs. 60,000
12-31 Salaries 360,000
Accrued salaries payable 360,000
Share basis 20,000
Multiply: FV 54
Total 1,080,000
Accrued liability 2018 (1,080,000x1/3) 360,000
2019
12-31 Salaries 60,000
Share options outs. 60,000
12-31 Salaries 520,000
Accrued salaries payable 520,000
Share basis 20,000
Multiply: FV 66
Total 1,320,000
Accrued liability 2019 (1,320,000x2/3) 880,000
Accrued liability 2018 (360,000)
Compensation expense for 2019 520,000
2020
12-31 Salaries 60,000
Share options outs. 60,000
12-31 Salaries 420,000
Accrued salaries payable 420,000
Share basis 20,000
Multiply: FV 65
Accrued liability 2020 1,300,000
Accrued liability 2019 (880,000)
Compensation expense 420,000
3. 2020 (Cash alt.)
12-31 Accrued salaries payable 1,300,000
Share salaries payable 180,000
Cash 1,300,000
Share premium 180,000
4. 2020 (Share alt.)
12-31 Accrued salaries payable 1,300,000
Share options outstanding 180,000
Cash (25,000 x P30) 750,000
Share premium 730,000